erlotinib hydrochloride has been researched along with sotorasib in 1 studies
| Studies (erlotinib hydrochloride) | Trials (erlotinib hydrochloride) | Recent Studies (post-2010) (erlotinib hydrochloride) | Studies (sotorasib) | Trials (sotorasib) | Recent Studies (post-2010) (sotorasib) |
|---|---|---|---|---|---|
| 4,353 | 786 | 3,033 | 78 | 6 | 76 |
| Protein | Taxonomy | erlotinib hydrochloride (IC50) | sotorasib (IC50) |
|---|---|---|---|
| GTPase KRas | Homo sapiens (human) | 0.0359 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beijnen, JH; Loos, NHC; Retmana, IA; Schinkel, AH; Sparidans, RW | 1 |
1 other study(ies) available for erlotinib hydrochloride and sotorasib
| Article | Year |
|---|---|
Validated LC-MS/MS method for simultaneous quantification of KRAS
Topics: Animals; Chromatography, High Pressure Liquid; Chromatography, Liquid; Erlotinib Hydrochloride; Humans; Mice; Proto-Oncogene Proteins p21(ras); Reproducibility of Results; Tandem Mass Spectrometry | 2023 |